Chemed Corp. Stock Hits Day Low of $385 Amid Price Pressure

Chemed Corp., a small-cap player in the hospital industry, has experienced significant volatility today, with the stock dropping by 15.0%. The stock reached an intraday low of USD 385.00, reflecting a challenging trading environment. Over the past week, Chemed Corp. has seen a decline of 15.99%, while its performance over the last month shows a decrease of 11.47%. In terms of longer-term performance, the stock has underperformed the S&P 500, with a one-year decline of 27.33% compared to the index's gain of 12.95%. Year-to-date, Chemed Corp. is down 7.3%, and its three-year performance shows a notable drop of 25.16%. Despite these challenges, the company maintains a high return on equity (ROE) of 25.88% and a low debt-to-equity ratio, indicating efficient management. However, the stock's valuation appears elevated, trading at a price-to-book ratio of 15.56, which is above historical averages for its peers. The company has reported modest growth in net sales and operating profit over the past five years, raising questions about its long-term growth trajectory.